Global Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Global Health Limited (Medanta) has filed a routine compliance certificate for Q4 FY2026 (quarter ended March 31, 2026). The Registrar and Transfer Agent, KFin Technologies Limited, has confirmed that there were zero securities dematerialized or rematerialized during the period. As a result, no specific intimation was required to be sent to depositories (NSDL/CDSL) or stock exchanges under the SEBI regulations. This is a standard regulatory filing with no material impact on the company's shareholding or capital structure.
This is a routine nil-return filing with no impact on shareholders or stock price. It simply confirms no demat activity occurred during the quarter.